Interview with the Innovators
Supported byAsk the Experts

Dose Escalation for Optimizing Regorafenib Treatment

Tanios S. Bekaii-Saab, MD, FACP
Professor, Mayo Clinic College of Medicine and Science
Program Leader, Gastrointestinal Cancer,
Mayo Clinic Cancer Center Consultant
Mayo Clinic, Phoenix, AZ
Daniel Ahn, DO, MS
Assistant Professor of Medicine
Mayo Clinic, AZ
Dr. Bekaii-Saab and Dr. Ahn discuss the best approach and clinical benefits of optimizing the dose of Regorafenib for improved outcomes.

Related Items

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: